Anatoly Langer

8.7k total citations · 1 hit paper
159 papers, 6.3k citations indexed

About

Anatoly Langer is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anatoly Langer has authored 159 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Cardiology and Cardiovascular Medicine, 69 papers in Surgery and 48 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anatoly Langer's work include Acute Myocardial Infarction Research (72 papers), Cardiac Imaging and Diagnostics (48 papers) and Lipoproteins and Cardiovascular Health (33 papers). Anatoly Langer is often cited by papers focused on Acute Myocardial Infarction Research (72 papers), Cardiac Imaging and Diagnostics (48 papers) and Lipoproteins and Cardiovascular Health (33 papers). Anatoly Langer collaborates with scholars based in Canada, United Kingdom and United States. Anatoly Langer's co-authors include Shaun G. Goodman, Mary Tan, Paul W. Armstrong, David Fitchett, Andrew T. Yan, Raymond T. Yan, Michael R. Freeman, Robert M. Califf, Keith A.A. Fox and Gregg Fromell and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Anatoly Langer

159 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

1997 1.0k citations Christine Demers, Enrique Gurfinkel et al. profile →

Peers

Countries citing papers authored by Anatoly Langer

Since Specialization

Citations

This map shows the geographic impact of Anatoly Langer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anatoly Langer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anatoly Langer more than expected).

Fields of papers citing papers by Anatoly Langer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anatoly Langer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anatoly Langer. The network helps show where Anatoly Langer may publish in the future.

Co-authorship network of co-authors of Anatoly Langer

This figure shows the co-authorship network connecting the top 25 collaborators of Anatoly Langer. A scholar is included among the top collaborators of Anatoly Langer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anatoly Langer. Anatoly Langer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glycemic Control and Cardiovascular Risk Factor Management in Adults With Type 2 Diabetes With and Without Chronic Kidney Disease Before Sodium-Glucose Cotransporter Protein 2 Inhibitors: Insights From the Diabetes Mellitus Status in Canada Survey 2021 ·Canadian Journal of Diabetes ·Hirmand Nouraei, Lawrence A. Leiter, Mary Tan, Anatoly Langer, Hwee Teoh, Alice Cheng, Ron Wald, Kim A. Connelly, Shaun G. Goodman, Andrew T. Yan	2
2	Can Clinical Reminder Help Optimize the Use of Secondary Prevention Therapies in Non-STElevation Acute Coronary Syndrome? 2018 ·Anatoly Langer, Mary Tan, (unknown), (unknown), John D. Graham, Prakash Krishnan, (unknown), Virginie Bernier, Shaun G. Goodman	3
3	Blood Pressure Management in Adults With Type 2 Diabetes: Insights From the Diabetes Mellitus Status in Canada (DM-SCAN) Survey 2017 ·Canadian Journal of Diabetes ·(unknown), Shaun G. Goodman, Lawrence A. Leiter, Anatoly Langer, Hwee Teoh, Deepak L. Bhatt, Alice Cheng, Mary Tan, Thomas Ransom, Kim A. Connelly, Andrew T. Yan	12
4	The Risk Stratification and Stroke Prevention Therapy Care Gap in Canadian Atrial Fibrillation Patients 2015 ·Canadian Journal of Cardiology ·Paul Angaran, Paul Dorian, Mary Tan, Charles R. Kerr, Martin S. Green, David J. Gladstone, L. Brent Mitchell, (unknown), Jafna L. Cox, Mario Talajic, Peter Lin, Anatoly Langer, (unknown), Shaun G. Goodman	8
5	Prognostic significance of low QRS voltage on the admission electrocardiogram in acute coronary syndromes 2015 ·International Journal of Cardiology ·Nigel S. Tan, Shaun G. Goodman, Raymond T. Yan, Mary Tan, Keith A.A. Fox, Joel M. Gore, David Brieger, Philippe Gabríel Steg, Anatoly Langer, Andrew T. Yan	15
6	Identification and Management of Patients at Elevated Cardiometabolic Risk in Canadian Primary Care: How Well Are We Doing? 2013 ·Canadian Journal of Cardiology ·Hwee Teoh, Jean‐Pierre Després, Robert Dufour, David Fitchett, (unknown), Shaun G. Goodman, Stewart B. Harris, Anatoly Langer, David C.W. Lau, Eva Lonn, G.B. John Mancini, Philip A. McFarlane, Paul Poirier, Rémi Rabasa‐Lhoret, Mary Tan, Lawrence A. Leiter	14
7	The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH 2011 ·Annals of the Rheumatic Diseases ·Philip J. Clements, Mary Tan, Vallerie V. McLaughlin, Ronald J. Oudiz, Victor F. Tapson, Richard N. Channick, Lewis J. Rubin, Anatoly Langer	54
8	Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada 2010 ·Canadian Journal of Cardiology ·(unknown), Amparo Casanova, Hwee Teoh, Keith Dawson, Hertzel C. Gerstein, David Fitchett, Stewart B. Harris, George Honos, Philip A. McFarlane, Andrew Steele, Ehud Ur, Jean‐François Yale, Anatoly Langer, Shaun G. Goodman, Lawrence A. Leiter	70
9	Contemporary Trends in the Diagnosis and Management of PAH: An Initiative To Close the Care Gap 2010 ·CHEST Journal ·Vallerie V. McLaughlin, Anatoly Langer, (unknown), Amparo Casanova, Mary Tan, Philip J. Clements, Ronald J. Oudiz, Victor F. Tapson, Richard N. Channick, Lewis J. Rubin	2
10	Smoking status and antithrombin therapy in patients with non–ST-segment elevation acute coronary syndrome 2008 ·American Heart Journal ·Steve Leung, Dianne Gallup, Kenneth W. Mahaffey, Marc Cohen, Elliott M. Antman, Shaun G. Goodman, Robert A. Harrington, Anatoly Langer, Philip E. Aylward, James J. Ferguson, Robert M. Califf	5
11	Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: An international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II 2007 ·Canadian Journal of Cardiology ·Mohammad I. Zia, Shaun G. Goodman, Eric D. Peterson, Jyotsna Mulgund, Anita Y. Chen, Anatoly Langer, Mary Tan, E. Magnus Ohman, W. Brian Gibler, Charles V. Pollack, Matthew T. Roe	30
12	Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: A substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration 2007 ·American Heart Journal ·Luis Miguel Blanco‐Colio, José Luis Martín‐Ventura, Eduardo de Teresa, Csaba Farsang, Allan Gaw, Gianfranco Gensini, Lawrence A. Leiter, Anatoly Langer, Pierre Martineau, Jesús Egido	73
13	Supporting a call to action for peripheral artery disease: Insights from two prospective clinical registries 2006 ·Journal of Vascular Surgery ·Daniel G. Hackam, Mary Tan, Peter Lin, (unknown), Shahin Jaffer, (unknown), (unknown), Etienne A. Grima, Anatoly Langer, Shaun G. Goodman	13
14	The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: The Enoxaparin in Non–Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory Substudy 2006 ·American Heart Journal ·Shaun G. Goodman, Gerardo Bozovich, Mary Tan, (unknown), Enrique Gurfinkel, Marc Cohen, Anatoly Langer	8
15	Are Canadian guidelines for cholesterol lowering in high-risk patients optimal? 2005 ·PubMed ·David Fitchett, Lawrence A. Leiter, Jean‐Claude Tardif, Shaun G. Goodman, Anatoly Langer	3
16	Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients 2004 ·European Heart Journal ·Andrew T. Yan, R.H. Yan, Meng-Hee Tan, Chung‐Wai Chow, (unknown), Eric Stanton, Anatoly Langer, Stuart B. Goodman	25
17	Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52. 2000 ·Journal of the American College of Cardiology ·Shaun G. Goodman, Marc Cohen, Frédérique Bigonzi, David Radley, Gregg Fromell, Enrique Gurfinkel, (unknown), Christine Demers, Alexander G.G. Turpie, Robert M. Califf, Keith A.A. Fox, Anatoly Langer	105
18	Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial 1998 ·The American Journal of Cardiology ·Marc Cohen, Christine Demers, Enrique Gurfinkel, Alexander G.G. Turpie, Gregg Fromell, Shaun G. Goodman, Anatoly Langer, Robert M. Califf, Keith A.A. Fox, Jerôme Premmereur, Frédérique Bigonzi	68
19	Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries. 1997 ·PubMed ·Jafna L. Cox, (unknown), Anatoly Langer, Paul W. Armstrong, C. David Naylor	27
20	Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease 1994 ·The American Journal of Cardiology ·(unknown), Anatoly Langer, (unknown), Gary E. Raskob, (unknown), Richard J. Gray, Jack H. Hall, (unknown), Tsushung A. Hua, Robert J. Lee, Valentı́n Fuster	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact